Institutional Ownership
Corvus Pharmaceuticals Inc
CUSIP 221015100COMCRVSQ1 2026
Institutional Holders
160
13F filers
Shares Held
65.52M
Aggregate institutional
Institutional Value
$912.72M
Q1 2026
Net New Holders
+40
63 new · 23 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions63
Increased55
Decreased30
Sold out23
Institutional Holders
160 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 7.17M | $104.82M | 0 | Held |
| 2 | Blackrock, Inc. | 6.16M | $90.13M | +1.10M | Added |
| 3 | State Street Corp | 3.57M | $52.17M | +777.8K | Added |
| 4 | Adams Street Partners LLC | 3.28M | $47.92M | 0 | Held |
| 5 | Vivo Capital, LLC | 2.81M | $41.05M | +571.3K | Added |
| 6 | Morgan Stanley | 2.50M | $36.56M | −1.07M | Reduced |
| 7 | Deep Track Capital, LP | 2.49M | $36.45M | +2.49M | New |
| 8 | Wellington Management Group LLP | 2.32M | $33.92M | +2.00M | Added |
| 9 | Perceptive Advisors LLC | 2.29M | $33.54M | +1.60M | Added |
| 10 | Commodore Capital LP | 2.26M | $33.05M | +2.26M | New |
150 more institutional holders on Premium
See every fund holding Corvus Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders